The Influence of COVID-19 on the Push For Provider Status for Pharmacists

Video

Ken Perez, MBA, vice president of healthcare policy and government affairs at Omnicell, discussed the pandemic's impact on the legislative push to grant pharmacists provider status for Medicare Part B.

Pharmacy Times interviewed Ken Perez, MBA, vice president of healthcare policy and government affairs at Omnicell, on the House and Senate bills, HR2759 and S1362 respectively, intended to grant pharmacists provider status for Medicare Part B.

In this discussion, Perez describes how the pandemic helped display the value of pharmacists and give greater visibility to the role they play in health care. He also points to the shortage of primary care physicians as providing the impetus for this legislation.

Related Videos
Semaglutide Ozempic injection control blood sugar levels | Image Credit: myskin - stock.adobe.com
Image credit: motortion | stock.adobe.com - Young depressed woman talking to lady psychologist during session, mental health
Image credit:  JPC-PROD | stock.adobe.com - Choosing method of contraception : Birth control pills, an injection syringe, condom, IUD-method, on grey
Semaglutide Ozempic injection control blood sugar levels | Image Credit: myskin - stock.adobe.com
Health care provider examining MRI images of patient with multiple sclerosis -- Image credit: New Africa | stock.adobe.com
© 2024 MJH Life Sciences

All rights reserved.